<SEC-DOCUMENT>0001079973-13-000293.txt : 20130715
<SEC-HEADER>0001079973-13-000293.hdr.sgml : 20130715
<ACCEPTANCE-DATETIME>20130426121416
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001079973-13-000293
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20130426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Venaxis, Inc.
		CENTRAL INDEX KEY:			0001167419
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				841553387
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		1585 S. PERRY STREET
		CITY:			CASTLE ROCK
		STATE:			CO
		ZIP:			80104
		BUSINESS PHONE:		(303) 794-2000

	MAIL ADDRESS:	
		STREET 1:		1585 S. PERRY STREET
		CITY:			CASTLE ROCK
		STATE:			CO
		ZIP:			80104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AspenBio Pharma, Inc.
		DATE OF NAME CHANGE:	20051110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ASPENBIO INC
		DATE OF NAME CHANGE:	20020213
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
<head>
    <title>appy_corresp.htm</title>
    <!--Licensed to: Edgar Technology & Business Services Inc-->
    <!--Document Created using EDGARizerAgent 5.4.3.1-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="TEXT-INDENT: 0pt; DISPLAY: inline; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; FONT-SIZE: 10pt; MARGIN-RIGHT: 2%">
<div style="TEXT-ALIGN: right">Correspondence</div>

<div>&#160;</div>

<div><img src="venaxis.jpg" alt=""></div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">April 26, 2013</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By Electronic Filing</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">United States Securities and Exchange Commission</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Division of Corporation Finance</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">100 F Street NE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Washington, DC 20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Attention:&#160;&#160;Jeffrey P. Riedler</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#160;&#160;&#160;&#160;Assistant Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: ; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 63pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Re:&#160;</font></div>
</td>
<td align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Venaxis, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Preliminary Proxy Statement on Schedule 14A</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Filed April 19, 2013</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">File No. 001-33675</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dear Mr. Riedler:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This responds to the Staff's comment letter dated April 24, 2013, regarding the Preliminary Proxy Statement filed by Venaxis, Inc. (the &#8220;Company&#8221;) on April 19, 2013 (the "Preliminary Proxy Statement").&#160;&#160;For your convenience, the Staff's comment has been reproduced below, followed by the Company's response.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Proposal Two - Approval of Amendment to the Company&#8217;s Articles of Incorporation, page 28</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We note your disclosure that you are seeking to increase your authorized shares in order to provide the company with the ability to pursue financing or other strategic opportunities.&#160;&#160;Please disclose whether you currently have, or do not have, any plans with respect to the increased number of authorized shares of common stock available for issuance if Proposal Two is approved.&#160;&#160;If such plans exist, please disclose all material information.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">RESPONSE:&#160;&#160;We would propose to include the following disclosure in Proposal Two of our Proxy Statement for our 2013 Annual Meeting of Shareholders.&#160;&#160;We would appreciate the opportunity to address any comments the Staff&#160;&#160;may have to this additional disclosure prior to making an amended filing, and would propose that such filing be a definitive proxy statement on Schedule 14A.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;As a company with significant capital needs for its product development, clinical and regulatory activities, the Company continues to pursue equity financing as a principal means of raising capital.&#160; In June and November 2012, the Company completed public offerings of a total of 8,337,900 shares of its Common Stock. In December 2012, the Company also issued "engagement award" stock options to purchase a total of 451,066 shares of Common Stock, which included 384,842 stock options granted to its executive officers and non-employee directors.&#160;&#160;The Company expects to pursue additional capital-raising transactions in 2013 to support its <font style="FONT-STYLE: italic; DISPLAY: inline">APPY1</font> product development efforts.&#160; While we believe our current authorized but unissued shares of Common Stock will be sufficient for any near-term capital-raising transaction, and we do not have any current plans with respect to issuance of the increased number of authorized shares of Common Stock, we also believe that the requested increase in authorized shares will provide us with the ability to pursue additional future transactions.&#8221;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div>Securities and Exchange Commission</div>

<div>April 26, 2013</div>

<div>Page 2</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, the Company hereby acknowledges that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the Company is responsible for the adequacy and accuracy of the disclosure in the filing;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">staff comments or changes to disclosure in response to staff comments in the filing do not foreclose the Commission from taking any action with respect to the filing; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Please direct any questions or comments to me at (303) 794-2000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Sincerely yours,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">/s/ Jeffrey McGonegal</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jeffrey G. McGonegal</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Venaxis, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">cc:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amy Reischauer, Securities and Exchange Commission</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Stephen Lundy, Venaxis, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Mary Mullany, Ballard Spahr LLP</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>venaxis.jpg
<TEXT>
begin 644 venaxis.jpg
M_]C_X``02D9)1@`!`0$`2`!(``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`!;`+0#`2(``A$!`Q$!_\0`
M'0`!``,``P$!`0````````````@)"@8'"P0#!?_$`#<0``$$`@(!`P,"`@@'
M`0````4"`P0&`0<`"`D*$1(3%!46(1@B%S$X87%XN/`C)#EYD:&WP?_$`!T!
M`0`!!`,!```````````````$`P4'"`$"!@G_Q``V$0`"`@(!`P,"!`0#"0``
M```!`@,$!1$`!A(A!Q,Q(D$(%!4R(T)1<21A@3,T4E-B=)'!T?_:``P#`0`"
M$0,1`#\`W\<<<<<<<<<<<<<<<<<<<<<<<<<9_P`?;_?_`.\<_"5*C0HTB;-D
M,1(<1AZ5+ERG6X\:+&CMJ=?D2'W5(:989:0MQYUU:6VVTJ6M24ISG#Y^/G[<
M<H_O]OM]EO%G,V4J7CG(UC-1?M4SY<;]-9'DY$-D0*;:>1^,;%-QT1TJC_3?
M?=:7,E.ORWWI#EKO7:Q6*U:9HQVTNOR3,N$2:=F2FU(DD8(\Z4&ABC^58QEY
MXH%ACR#LO/O]ZN5F9C.</XSFCG>'FS\4$/;CT)R@[7WXN`12.,[>U3KL--UE
M)D0'OLGI#LJS[`H)39(F$F/AJ.>K=/NX(V,98<KA(V+=B./7>=<NQ&BNT6J@
M>V.NM[!7_6L]Q\1"GA(LX2Z%("4,-RZT>JYB")L%/.BV'HBY%:L0806API4"
M2J`B%-A//9<Z\ZWQ?4G3>`Q5+IV3%3XZ2&22=XZZPUDCIR0-0Q[1%I'J3M)'
M,YF2J_=4@_@N=LNE/X=/P_\`6'I9ZH>H?5_4'J74ZMQ_4E6_4K4JUC(RWLS8
MMYFGDH^I>I8K<<56',48:L]*%*,^5C[<OD"+T*%89>]....8CYNMQQQQQQQQ
MQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQSK*)M^A2]C&-5?
MF/M;H':AN+'S8[T2.07,&13.(H><\E,4E.C"YT.;)A1W,R41W7'&FWD0B"HE
M=/G'.W.O>+7M/+I$PK`FD!^K:Q9)(53^)N=:W'=VM:GM>&_AAIQ2@A76IJU"
M;5ES+4=JJSC;\AU#+2_?B79+*OX@-EO,NNL2(Y>J/QI$=UQB5%E1Z#35LR8T
MAI2'HTF.ZVAUA]I:'6EI0XVI*DISB0^J-^5?9U9+:/[#0`I\5<P).ERYMD@P
MYE7V!7;".?"F*C>!\E"AV9!D;,D#7E26?Q%DBR7H$M$8BMILQF/-^EENGTY@
M>J\%^8R5>?"X?*9?'.%DMUY;-"M<LV*@CC0STO<D?O@['LU8P)"]F'W9*^C7
M0?XO<1F?4WU$](/4;],Z9O4.O>MNDNBNJ(&EK8;(U,7U%E,+BL5G#9L3#'YQ
MH:T*P9`31XW,6&-40XR\:<&2\YY"4H2E"$I2A*<)0E.,82E.,>R<)QC]L8QC
MVQC&/VQC^KFF'TR)JZHW1W$JXY<IW62]=:=LMF84ZXX.%;&<L5Z$565%84M4
M>$3LM5B6EDJ\PVW(*PZB!1-6ZV''89DEL?TRNGBUZ>*:@[2;(U;K&60>EKUS
M8Z,$VH7`P7Y"G<@:AL(A9:R2C"AT=6((>1>`VPCS3#33AHV>EX>D/3><)=,_
M"+UZ9U/JD27M^QKG(E6J)6S)^`3VQMZSK8:#_K[9UEA"8(RMU:&@>P*Q/'5H
M378#$&4-I%2E$43H*_)X3#9CK;*4>E^D\7<SN=S$RUZ./IQ;E9@1+)+*\A2&
M"O!$CS6;<\L=2G`DMFS/%7B>0;)6YZ71%:UU3U9DJ>"P6&BDGN9"S84HP93#
M'%#'$'FGEG>01P5HXFLV962O7@DGD1>6,]CNS^F.J=$5L#<]J0!&/OKA`P\&
M,Z6M5K*(1AQ0NKUZ)\IQ:4VVI+LQY"6APJ,K$TO.'P<*DI[AJEG!W>KUNYUB
M<DI6K<`#V>O$TLR8R2(,^.C%1,Y,>8S'EL)EP)<>1AF4PQ):PYA#[+3J5(3A
M$W[O+:79"^6#:^XK'^?M1*)*BCX<1MZ%5Z6`QEUZ)4J0&=D2L!*Z/^>?9+DF
M65+2LOF;$4,'9L\G)VJ]1E?/JCUC7\<I^?7K2ROCG^M/RUO6L_'/M^WOCW]L
M_P!_,\>N_P"'&OZ(=`=`Y2_F9\KUAU!E,I6ZA2LT8P%-8J-.S6I8Q'K)=G>I
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M:RR#O`V/EL-96V<JP\TG.7$ASS+6,+(AW',J4SG.<S!$A:Y0U>$/$(1'-_IO
MZKS8`5\'U"\EC"`I%4NZ:2UB%\*B,!W26,=&-`1*&FJ1C_#!XT6J=`OQ1_@Z
MH^H9R?J!Z95JN-Z[D$UW-]/;BK8KK24]TEBQ"SE*^,ZFL[9FLR&/'YFP=Y-J
MMJ>?+<JPV+W\VAUCT`<<'@A=^/))!:GKHK:)\M+58G&F"*D.V-F.G$RT@P\8
M:[)'0$$!1++J6Q+I;\<]'=$9Q;O=K=L2W679.RK44N5YM<U16T6T^^VY/(/I
M;2TRWA#2&80L0,B-LCPH,7'A!`(F-$%"($(=$CQF[:/(A6;#0]2N5JW"I(DY
M#VA1\?:90N0DBT_`N#,.6%=:2K!>(0<0IN$[#PXMU["X:VVIS$B,S(7Q[^)U
M2L5_>O;JN)S(SF(:H>@3+"7&AJ,?&0/L&X(3F%-2C#O_``Y4/6SZ7(05KZ2+
MLB4;>G5>N_07T]ZK]&_0STWS/JE>J8NOF>K,M=JU&Q'LV,YU6M:KC;4.-PB&
M5HH,;[TJ7LG8K_E<4DTM>WD9)K;8^.33_P!/\-ZY^NC87TNR60Z@NP=`SV,=
M8AZF6S5J=&0PRFNYZ@:6!+D^3I@SX_&U\C^;S*U8I,=CQ%1@L^S'#Q^^+<_V
M&0"W+V%'%:GH:4F.4K%&=S,#6W<8]Q"'HI*:XVJ,2JVM";:DN0YS*XMBN8U6
M)P)P2`FB;&4U/P($$5!AC!D.*.&CHL>`/'P8[,2#`@Q&D1XD*'$CH;8C18L=
MMMB/'8;0TRRVAMM"4)2G'U_^_P#?]W'/G3ZQ^M/6'K3U$,SU),M;&T38BZ>Z
M<J.YQF!ISM&9$B[@AMY"T(8#DLK,BSW7AB14K4J]*E5^L_I+Z/\`2GI!@/TG
MI^$V<C<6!\]U!:C1<CFK4"L$>7M+"K1@:2;\AC87:"HDLC,]BU-:MV'''',0
M\RMQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQSB-
MEH%)N)*IE[74Z_8R=$/)M%.G&14,C*K5B1#E0&C(9Z2TXJ"09C3'\,R&O9QE
M[Z$IK*)46*\SR[CCE62>>6."*6:62*LCQUHI)'>.O')(\TB0(S%84>:1Y76,
M*K2N\C`NS$QXJM6"6U/!6KPSW94GNS10QQRVYXZ\-6.:U(BJ]B6.K7@K))*7
M=*\$,*D1QHJN...4N2...............................>>/N<?LKQ'^
M4\I8X<RVFH.H=OQ-TU;XDR>96VNLNTYA24;KC3IR6Y'+DWZ85ONH99TBP[":
MV=32)^(RI0V&[CT&:I::[>:M6[M4#$&Q5*X``]IJ]@%OXDC#M=L`Z,6"&!TE
M/\LB"3&2XTV(^G]G8[[;F/V5S.SZC7J1_2%H2B]OZF+P];NN9/\`3&R5Q(Z,
MS"VC=AE((]Z=*Q'BNSB6=<;`77CL-MQYH=7ZI9=G')&4(^LOD7.AWE9D:/\`
M#EOP40*M2M[=/Y`O3&CV2>4$7C</>SQAOK-.D1"?TH!,7K:?&O(>?5X.5+8U
M7HM<ES&79*UYNLRFY7KS(-S!Q7D^!LDJ%8_T'<P/C_F'P`.>3IRIA<CD*4Q[
M*DD<E^L3]E1"[HO_`!'L5XP"=DUM_+\@?Y@=^W_OKY'5Z`TU.G'`VL[D'ZDZ
M3KC)LM!KAK=!>RL!MHW0FPWA#`S#&PY2:+8#V4R1\2EZDBV7#S,)Z8XJ_COC
MW0!>'/IMUWZT:7>;V/O=>M0NL-2.7]Z>89%U76->"@+/NO9##$Y,F6WB8^.9
M"UELH-18K085$%+16ZQ8<#:FO3@]1W-@;WOO;RU1I1&L==Q\W6FMBA)QZ6^9
MWCL0!AR_6-1%4Q4I\O3=6G<#"?Y%F2T47NI4U+V2`=:T1.\^%S*6?R8[H@V)
MU38S5^I],:^KB\IRG#%4?I3VTYCR,_''SRJT;*M&7'L?-2LL(94K.(S;;<DQ
MQR6(:8'\*I'WR#QN1_H&F^W\P+`?=G'QY%N%BQ6QUS,L2EO)V?8A?>_9@!<E
MDW_E$T:$CPL4,@+`>?WU)TI\LWE?%R=YG-B66S40X0(20&Q.RFZ[?KW5]C(1
M9*HQ9&I-6:\K5NC`J_&FM*88G5+4]5U_*G-S8H@O-G0"K<7XP>_O*'X:-[`:
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MW$(NWL9;&H#Q"/#-:](A+`!MT:#*(1X1D`4CQ)4YIEM]W"QV0[^]XO)YOF+3
M=>E]RP:OLBP3P6CNIVG[$7JS+U:PTZ1AYV,U638B'=[(Q7QB[3?K/?C4RD4C
M#!\@+75*C`D.(N2ZW4'?&D_3Q]YJCNBAWK5A=VH=ND5&E[&KI*JV8?KB\UW$
M4KF36#C,4N&AV"R&-@$(C1"%">F1R>#$=E<0A%E2(>>FX`BR'>+;IZ7%;?(U
MCJR;BA77$X6F#BS;3UN@I(80K&4M2W(X&+$;E-X2^W#D3XJ5X8FR6W(L$<==
M;DX593!(R1%O(`!&B"/NW<H+`[`!T1LGEWOV+.1?#47>2LMV&.:T$VC,Q\.-
M$_M4([(C@J&=&=25`$*;#XA_*?JT#,V.YUEV=#36X;AN8_K;=NM[1L$2S&9S
M*>D"J_KS;)*Z'2;"D82V.H\2PFY,CVR/A2\8RYBR7PC>6+=4O>E'ZD]CMGV/
M<FN-R,DANFMD["-.V6^4G8407/LXZK'[Z;EKL-PJ-['P"XL(_:9]ALH>Y*JU
M=%3,@#'V@;8SSSDY8^%4?,*R,K\5@8-K7F$#10@Z`TW`@C1<;OH/Q%"P8T)#
M+,,3$'N?AXT*.A#+(M"(:4?13\,]H9OS\<\<T<89(RZ.H(*GX\%BQ&F[3X(V
M-@[Y2N4OT&S0GI6+!6:<1SQRNK"108]J>Q(U*LA8:925;M=""!K9IY2O(W7?
M'?I$98!X0?=]Z[5F&*SHS7Y22[&"3"H>'$DV.^71<.1&*JU[KQ@J&DV"&%=9
M+V`R<JU.B$:YBSNVVO8[@50\K/EC,6FWCG=]=D00@TN$=G2[^%U/UXJ1I,>,
MMVOU.MG+9K_4J38V"X*_,":0'.W5B)*$%KBJ0Y/9*R93>I'M=BD]]Q0N2Y-_
M%43J!K^=4Q;CRUP<S+'L+=T\^=@QU?R,R3<@"$!D'6\8^Y13QS:\YS%QC&P[
MIOJJB:1ZI=>=6ZT;@_HNI:CH\83/@,QF6["^0!1#!FX2U1$-LRB]V.D2=N/$
ML)^H5-FR!-]2WY;JU4T9:56&58T>:?9[G!(50`V@05(T"O@$$GN).@`)<L<N
M<RERI+8EAI4>U#%"P5I7.QW-W!D)+K(>YD?M1450K.S<P0WAGR6>."9,U9L<
MOV&Z_P!?VM2[M4&Z>8V"B_Z4OM;L@217[0BJNA[5>]61[>/%D69?W]6G!=H4
MU,D5/=6$1,C_`'%K'ID7),???;@:B>27`SIS3<A4)\F0D0URHUSV"PQ+5$D2
M78^933+KS3<GZ?UT-/O-I<PAUQ*KWO,MK.C;,\:W:K];QQ_U=<ZW)[AHI67'
MC+G!MD:R1FST]0.8^TX\,(V6=$70Y;\%;$HA7[<;`..J@&9K#]#_`*9G.?XB
MNVV/CG.,Z6U+G*_=/LG*;S>L)3G'O\LY7A2LXSC&4XPC.%9QG*<*J&<6*%F0
MQJCCL5^T:#=KQ%3YV?OK1)UK8.CH0UH''9_&UUGEF@(DD@$K=S1!HIU=-#2#
M;(&[D5`V]%=J28$>2_IIM'QA=Q!%WTW;;I6M=7>V3]P=7MFQK&;+DJ591!EL
MZ>U58YIN7.>-$**1F1E08UIR<B7_`%B6&L')ME*1K[%A:K>O7ENT-LOQ[G^\
M.R9L>HRM/B%`=^ZZ")S(-`-Q0_QX^'1Z=!)S49+-;1+EJ^_J5Z66^W(C[<$A
M6`L,+CK.R&DMY!NM6E>U74W;6MM\'1=&IHJN$MAPMM$F(:\Z2L=$%D#0[;<:
M1-DP&XK%2B-D5V5G!02R=I,RT54D2C!CY+*O-E'DB.0,L6T7FJ"FR%<L)D4/
MFFX5:L)VI0K)`J=CG`)J!V)I`#`N5L8K,TZ(:-`H-J.164#UE23#J)4R$*"3
M:RUV56<#]Z'6P3]BP!V?.G`.@'.^UMY>G+LS5@CU;\<CQP,W^QF70#=@\]D;
M,`NM!XF]HGNC5A8=1:IV7\S_`'WD1K#82@BS[6(O6J_F1Y$E,J/6WK]6W8@_
M\;5X*,,0?A6Q3XVGTR-D=#7?=H'6K';7X[YZW66-?[ZA:FBM,^.3J!IW7DRQ
M`Z%3.S&H-6"QOZHL$N;.H]$ZP=AHU;"V0S*(NEK2B(Y5J\2D/V"81?GFA$$U
M-<?*1VI2)>>"/KAIG3O1>B[9UQ9!FP+UV9@#]A[>O\&(J+ENQAGBH-C4,1J0
MC!"*(T:158Z2[$FKRN7=OUW:4116+0H1`C=ZFC^QIUM_SMU#_35VFYT,XEOU
MXD`6*"0(BZUY'@G^NAVA5!^%4'0);E5:)K8&];E?W;=Z%9I9>[N/9(R.B!AX
M/<&[Y&'AF;6V5$/.&^GKV<.U;XY.Y.R[N1/3:;IWLUMVYD&ONI9F8+J-3ZK=
M<KT>@@(I"9\&4K<4;)L#6'XD1XL1F25?3D3I+ZZ)$[*\BWF6["D*:)N-EL!F
MP`3VQ8FEH6U9VN-!:@UL$+AAN5N`H\\<.L*@!"Y5FM2+5-K]KV-9)Q:+)D_,
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M;FLGS9P>.H]8@291,T>O^IQ:6X;4B)5B3EB?B,*T+=C_`!Q]HM@;(VEL'07;
M"VZ<F6S>5&W/36Y6Y>QQD#7W*)UQW0)C5:=KIZ]3*&BF6+MC:=5;)M%%##8=
M2,:ZK)X%/'S7D"03]=G2;U'K1*>`HO>ZE5\".(JC#XG934,8@FI1%NYBQHD[
M:>LITTP3KPY:&Y$LY>J(?L`Q)"8Q[:WJ=;8FE8&K"!/@E8,(H+FQ"0PE$C3Q
MQ&!)9F09\&8RB1$FPI<=;D>5$E1W&WXTEAQQE]EQ#K2U(4E685N6RCJ98HHV
M[2O>B`K*.Y6\DEN[M('@G:[((`8CEXQ%7%V(915M6;$?>DGLSRE9*K=DL?TJ
M@3M#B1Q[B[#E%(D8Q@B-G3K2-WZYZ!KVG-@;&-[8,U*Z[I>#WJSV>UW*S$]>
M6?=VQ;?J8;9;/=IA"RE['5M6'Z;4STB=/FQT%@<R.*ER`[,!Y;DGN.6\DL2Q
M^223]O).SXYZ)(EC1(TV%C144;WI4"JNR023I1LD[/.*WJD539E(N.N+V$B6
M6C[`JMAI%RKA#ZOV%@JEK$3`-B"3?H.,O_:%1$^9`D_1>:=^B^OZ;C:_BK'F
M2=ANNM^ZU=B=I]4R8XS<;]KG9L/7E2C1HK2SFT$'%LYT><@"X3KD99[9-4N=
M;G0!L9UYP:6M<\`EQ,AJ8WSU!>40=L-(ZJL_FS\>MU/TL84LDK5^QBLN=)<G
MY8F%M0C[E9-9EI@M$M`B66IAX^0*A"<F"[/8F-BG5R',@`6!L_'V#`TH(+*8
MF?M!_FB'</\`0@%3_<'SV@<L74&/%V*LX8))'9BB[SO?MV9$B8>/DJY1UWXT
MK@$%R>6/=">J@CI9U,TWUY@.0YYRH5I)'8M@@_);%KVK:I+UFV58X\A^-&FO
M"IMO*%6:PP10Y,$5&*``*=6P)8QC.7ZD'IC8V+K3.\E4"S#&OB])$Z7[!)@0
M?JQZ60"F"K^L]B&W&$O/8"VR/;".N[`9G_:"P4^OZX&X<?DVG/T->O/YQ@.)
ML(DH`/BQQP$<'3@YH*8@QB8DP))QG81(64&S6GX9`<0AOO1)T&6R]&EQGG6'
MVG&G%HS'ALO#/[_[F);O!\=P;RWG['?D'[$`Z(&N3[N,@MX_\@/X2(D:P,!W
M>TT0`C.MCN&AVN"065F&P2",J7CY]0-K2BZ:H^F.ZH#8<:U:YKHZIA]ZTH$]
ML('?JW7XK8\$0O((=*<O(2^X%-081J8+#6T+:"$.?:7R=;>*HKT;F^_O4R:E
MK!^N1^O/7V\[#I0VR#9&S;SLV8-UNIZB1YD-P^C5529F&31JT20ZR&1+^P7M
M>#8):)%8E0"D*>Y+@UM^9_IYUOZM[?0SH'64/6<"RML&R(0)8;?(K<::2QF1
M):K]8+V`E7JF*2XO.(8*K#`P,:SA,<<.BQT(:3._PF="^HNUA#^Z=H:2KNQ]
M@4]^#(KDF^$[1;JL-F/*<6@EC7)\\0UQ*+P7F&98<Q-J<DH#G,M3P\N#-;0_
MBY/%1]LVS'*0WGVP0J]S=OV!V/+?9M#[+KQSS$-O.&R,.MJLLL6A^:,9=_;3
ML(^ID(<]NA]409M>9=_6;?\`R1WVJ[5\27:7:%%)+,4C9'4*PWVG%W1Y(2X5
MJMPI3%AKQ)P49B#RXQ<X01ARECRL"$2A*=S&G1(TIMUE&>STUG]LG?G^6-G_
M`.IU/FGWR.!1EBZ%]O0IB-F6-G]?MFMRXV'Y,7+J$5B>\E/UX;T>2W[.-H5G
M+3R,YQCXYSE.5)SG&]-&`$KWGV9M"XJLG(>IZ@`C3?N9>$MB2-O>(38OVF'\
M0EY>F"H#OW+D94IO#'TVGT-.OMN4(&'Z?;`!_>/]`QCUY^^M>?C_`-<N.05C
MU#AR2I/M."0"`2ONLQ`VV@?L"Q^=$^-G89SSH+?_`-9,O_WAQ?\`KO%\]%_F
M!S85%JS'G2D`FAJT"Y/D/J5V>C8(E<Y59I>X`5]D$DR,S<RFTN6Q:RWV+;R!
MJ/?[!N&D9C$/'&-.FL?]NQ_\.O\`]YSU*A88P@C_`'U4\_U?MT?[#M.^6Q^H
MOZ0VO8-<H?=[6M=E6.3IRG$M==@!HN,Y.,1],H+S;54M@LPVEYD/`-660U=<
MW-$*+-D0JW?I5P(?CZU2K`18CYXR//'0-"Z$I77/MM6+^3'ZI!C*CJC<>MP@
MVVQ9^M0L-42LU?85=07&'H1NG"6!=:`V&LC++&M`*+$?LC04V-FF+3L"Q^^,
M>_[^^/WQG^K/OC]_?',5WG'Z8=8NN5T#6W1>I`NK25\9R:L8^H%+*,J"R+LA
MYAUT)0$&U46ILNH90MV%4ZX$@N2,NRUQE2GWWG.:LT<\:5;",P4EHG709=^2
M"=C[;`.F&CHCPI'3+5[&.GES-&5$+JJVX)`2LA/8@90!H[[4+`E"K*SJY]QE
MYPKRP^:&%W;U^UUQT'3;90-"SC@<[LRW[&:##+IM2353#!RKU0-6A!8]'J]!
MA'Q@FVD210HFW6<D.#"7`]4###<:X]U^F8SC^(CMQGW_`&SI?47MG_&\7WV_
M\\[$\<W1OJE8.B_8SL+8].!+-N%C2.X`8RY6<Q:[&[78I#6=E:ESJ@%-GY]<
MIMB6P\_&;ME4#A[3'B2),2,89C2'VG/X'IFQ4!G9G;$NVRK!']`:I$_<9?D+
M_P"09L%SE-L996ZIC.4OK4YE_+7W"O?XK=4C&$XKR/"M6U7A1E$7MABVCW.S
M(Q;Y)^%`WXWX`50!RW5DN29G%7+DR2O:]YD"`A8HHX9-(`54#RY.AOSMF9F8
MGGV>H7\B3!F<]T%U586FZ[7\A[;VNLD%Q2&WIT;$>Q4G2")V5I1F/$2D5L/9
M.(C2DJS^A:N@O\57^N\Z\Z]^!:W;5\=5OVM;<%JGW+V6R$VMU_IY<G^)"U&D
M`ATN76=7W\2\ZS&AV#=PDM.G6J>:D,S]:D9FNF)HT62I%[!6FNCH#K6E[L\F
M^KZWMT.O9`:P[[N%YM$2Y%#)Y5OM(XE8KTDK<Y9`@]-N*B-JA,EK#$L\@M`M
M"E28EDBE8$V;%D>B+RE/*:<<,$'TDA99'/R[>/']B1H@_P`H5=D;W+QU5,W8
MNY"\.]"7J5X-DB%>W]P;0TR*^XR/B5I)=!NSMPI>$GR`$.F'8<KUNW6[.J.C
M]Z7K-6LD&WL3@TK0G9(=(Q3V"5@@2\-KK<"UD1T366T8Y6$U^`L`NF6$I.KP
M2NV^1.MX]31_8TZV_P"=NH?Z:^TW*AO4%ZEUS3N\LTK6*H."R]NZOKEPV-B$
MJ6B'9[0N06J\@[*&JDK&Q",\,"%L%)`R)"46EQW"I+[LM+F3I%E7E<&LW'PF
M=*[';))>RV(`_P!5[9!/G#ILH<?LTS0MMK,XZ:+S"#Q"R%"`>SGFB,RQ2"KQ
M"81>+35/ET,SFJS!&GI6U!4S.H=?^H#0/SK_`"/@;`#:V3R+&\T-#-8B1A*M
M)&>&79W[9D#%"->/LX&R%9F0$H%(YIZ;NQ@J?T5[:6VT%8(&LU;N%L"QV(X3
M?3%&A@03JMU;)ERQ"2OV1'A#A\61,E/KSA#3#+CBLXPG.><ET7ZE#ISL&:68
MW+KG<.A!*SAM=/N20,G<%5/T5$W**B<-P]<CY>Q*S;SPI39,U38^O;&%K3SN
M!\6^V125R<<O].97Q`WHGL*3$AI0[:^RU\-V#+KTB4V1)(USJ:L8?4S*=>9C
MM_@JZ'@*B1&V(:L1,R%1\RY,M]^LGS:]&NJ774P/NVC-.A=6&+DRZ6.#Z:9M
M8BF8FYD.,94#UTR?_H^JD=3;2,J@U:L!H"G<K?5&R^ZXXND5KS79XIED[G90
MCHP';VJ`VP?'GP02&^-:'SR:LN0J8;&V*<E<1Q1,;$4R,WN"1@T?:0.[Z1W!
ME5HR>[]YT.5G^5+;71G;/9N=LKI#64536!+7PR1LTK$H)G4M'MFRL$S4@E9J
M[KFT!:R9!3'@+PF-<"3U8KD2S'F'#.1LTO(-6,_MI\6E1V30_';T[J.VHA,9
M=P>BZ9%E!#;$B(:K=?7#5(H]4,0)C;,P85JE&>KE<(B);34H1,%O#9#:'HJT
MXSS^![ISUIW)8R.W=K:H#;!O&LW(1NDR;82L9FNA33<QI,0S^A)AERADBXMW
MX3@9,O6I\X"58BEPS\`I$BS&=B/.E^50L=50Q$/DNY!8G7:/(_UV?'@*`!H\
JK=/U96>?*S&%&N`A(:ZE(U5F5V9E8>&+*.T!GUMR78OX<<<<MG/3\__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
